Home
Tools
Models
App
Prompts
News
Topics
Submit for inclusion
English
English 日本語 한국어 Português español Deutsch Русский Français 繁體中文 简体中文
option
Home Close
Home
Tools
Category Ranking Generate Cover Generate Image Skill
Models
Large Language Model Multimodal Model
App
Prompts
Prompts Image Prompts
News
News Flash News
Topics
Submit for inclusion
Submit App Submit Tool
Create an account Sign In
Change Language English Change Language
Settings
English EN 日本語 JA 한국어 KO Português PT español ES Deutsch DE Русский RU Français FR 繁體中文 ZH-TW 简体中文 ZH-CN
Home
Flash News
Content
GaryWilson
GaryWilson
June 16, 2026

OpenRouter launched Fusion API, a multi-model collaboration system that sends queries to several models, uses a review model to analyze responses, and integrates the best answer. Tests show a Claude Opus4.8 and GPT-5.5 combination outperforms Claude Fable5, while a low-cost mix of Gemini3Flash, Kimi K2.6, and DeepSeek V4Pro halves costs with under 1% performance loss.

OpenRouter launched Fusion API, a multi-model collaboration system that sends queries to several models, uses a review model to analyze responses, and integrates the best answer. Tests show a Claude Opus4.8 and GPT-5.5 combination outperforms Claude Fable5, while a low-cost mix of Gemini3Flash, Kimi K2.6, and DeepSeek V4Pro halves costs with under 1% performance loss.
0
0
Share Click to copy the link
Comments (0)
0/300
Submit
Author IsabellaDavis IsabellaDavis September 18, 2026
US Judge Mark Pittman rejected OpenAI's motion to force Apple to disclose its confidential antitrust settlement with SpaceXAI. The ruling determined the agreement lacks relevance to the ongoing disputes between SpaceXAI and OpenAI. This follows a recent voluntary withdrawal of antitrust claims against Apple by X and SpaceXAI, while their case against OpenAI proceeds. OpenAI had sought disclosure to assess potential impacts on its own litigation, but the court found no necessity for public release.
0
0
Author EricRoberts EricRoberts September 18, 2026
Qwen3.8-Omni-Flash launched with 1M context supporting text image audio video. It boosts Agentic workflows for editing and production. Scores rose over 26% versus Qwen3.5-Omni-Plus with significant gains in audio visual agent and coding tasks. Audio video API prices dropped over 93%. The model matches Gemini3.8Flash in audio video while exceeding it in overall audio. Token consumption reduced by 45.7% via Agentic Understanding mode. The team used the model for its own R&D completing four iterations in 12 hours. A Realtime version supports sound localization and improved Sichuan dialect recognition accuracy by 40.7%.
0
0
/live/7431
Author RichardGonzález RichardGonzález September 18, 2026
China’s 14th Five-Year Plan for the Pharmaceutical Industry highlights AI and quantum computing to accelerate drug development. It promotes ultra-limit manufacturing, space-based pharma, and biomanufacturing while advancing gene editing, cell therapy, and organoids. Key breakthroughs include artificial life systems, radiopharmaceuticals, and xenotransplantation organs to foster new industry growth points through interdisciplinary integration of enterprises and research institutions.
0
0
Author DavidGonzález DavidGonzález September 18, 2026
Figure launched Helix2.5 humanoid robot neural network on Sept 17. Pre-trained on its Index dataset, the model boosted zero-shot success rates from 9% to 56% in 30 Bay Area households compared to models trained from scratch. Helix2.5 supports full-body actions like organizing living rooms and folding towels, achieving comparable success with half the adaptive data of Helix02. It demonstrates self-correction capabilities and follows scaling laws observed when doubling Index data. Index has amassed 16 million videos and 44,000 weekly active users, with Figure investing $3.5 billion in computing for the Helix series.
0
0
/live/7429
Author KeithYoung KeithYoung September 18, 2026
Anthropic launched a Life Sciences Certification Program applying to its core models Mythos 5.1, Opus 5, and Sonnet 5. This initiative establishes unified usage terms and clear compliance pathways for pharmaceutical, biotech, and research entities. By defining specific boundaries and responsibilities, the program addresses regulatory barriers, enabling these industries to integrate AI into R&D, literature review, and experimental assistance with standardized licensing rather than vague general terms.
0
0
OR